| 发明名称 |
Use of soluble guanylate cyclase activators for the treatment of Raynaud's Phenomenon |
| 摘要 |
The present invention relates to a method for prevention or treatment of primary and secondary Raynaud's phenomenon comprising administration of an effective amount of a compound selected from compounds of formulae I-IV, and to pharmaceutical compositions containing these compounds.
|
| 申请公布号 |
US2009215769(A1) |
申请公布日期 |
2009.08.27 |
| 申请号 |
US20060988991 |
申请日期 |
2006.07.04 |
| 申请人 |
BAYER HEALTHCARE AG |
发明人 |
KRAHN THOMAS;STASCH JOHANNES-PETER;WEIMANN GERRIT;THIELEMANN WOLFGANG |
| 分类号 |
A61K31/5377;A61K31/195;A61K31/505 |
主分类号 |
A61K31/5377 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
